Vania Lorvanis
Family · Newark, NJNPI 1386259018
Payments from drug & device makers
Across 106 payments — averaging $21.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$436
- Novartis$335
- Madrigal Pharmaceuticals$247
- Lilly USA, LLC$216
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$179
- Novo Nordisk$151
- plus $714 from 17 others
What the payments were for
- Food & beverage$2,278100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 15 | $436 |
| Novartis | 22 | $335 |
| Madrigal Pharmaceuticals | 2 | $247 |
| Lilly USA, LLC | 15 | $216 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 11 | $179 |
| Novo Nordisk | 4 | $151 |
| Amgen | 4 | $136 |
| Bayer | 6 | $105 |
| Boehringer Ingelheim | 5 | $81 |
| AstraZeneca | 5 | $76 |
| Mannkind Corporation | 1 | $50 |
| AbbVie | 3 | $47 |
| Phadia US Inc. | 2 | $34 |
| Pfizer | 2 | $33 |
| Exact Sciences | 1 | $20 |
| G Medical Diagnostic Services, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Scilex Pharmaceuticals Inc. | 1 | $17 |
| Corcept Therapeutics | 1 | $17 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| Merck | 1 | $15 |
| Amarin Pharma, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,278 in reported general payments places this provider in the 85th percentile of 2,692 family providers in New Jersey.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 93 | $84,798 |
| Repatha SureclickEvolocumab | 126 | $79,303 |
| TrulicityDulaglutide | 57 | $64,124 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 85 | $62,958 |
| MounjaroTirzepatide | 51 | $60,535 |
| FarxigaDapagliflozin Propanediol | 74 | $58,967 |
| OzempicSemaglutide | 51 | $49,332 |
| KerendiaFinerenone | 66 | $49,119 |
| RybelsusSemaglutide | 33 | $37,667 |
| EliquisApixaban | 52 | $36,377 |
| LinzessLinaclotide | 40 | $26,009 |
| JanumetSitagliptin Phos/Metformin Hcl | 19 | $18,990 |
| VascepaIcosapent Ethyl | 46 | $16,282 |
| EntrestoSacubitril/Valsartan | 22 | $13,777 |
| Trijardy XrEmpaglifloz/Linaglip/Metformin | 18 | $11,151 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $216 | $124,659108 claims |
| Boehringer IngelheimJardiance, Trijardy Xr | $81 | $95,949111 claims |
| Novo NordiskOzempic, Rybelsus | $151 | $86,99884 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $76 | $72,58299 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $436 | $68,607100 claims |
| BayerKerendia | $105 | $49,11966 claims |
| PfizerEliquis | $33 | $36,37752 claims |
| AbbVieLinzess | $47 | $26,00940 claims |
| MerckJanumet | $15 | $18,99019 claims |
| NovartisEntresto | $335 | $13,77722 claims |
| Scilex Pharmaceuticals Inc.Colchicine | $17 | $3,36252 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,692 family providers in New Jersey.
Other family in Newark
- Eileen ScarinciNewark$13K
- Jennifer DemaioMorristown$412K
- Kara TrlicaCranbury$186K
- Nicole BauerParamus$161K
- Angie GarciaWest New York$161K
- China BattistaWall Township$142K
- Nancy EisenbergerVoorhees$82K
- Jennifer AbitabiloGlen Ridge$54K
- Megan FiloramoMorristown$53K
- Shawn DenningToms River$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.